Blog

26 August 2015 - Crohn’s disease patients can now get routine access to treatment with Takeda’s biologic Entyvio on the National ...

26 August 2015 - Updated frequently asked questions have been prepared that provide further detail on the 1 September 2015 changes ...

25 August 2015 - The Items for inclusion in the PBAC Guidelines Review are now published on the PBS website. ...

20 August 2015 - A Tasmanian man with hepatitis C is taking on a global pharmaceutical company for what he says ...

17 August 2015 - Afatinib dimaleate (trade name: Giotrif) has been approved since September 2013 for the treatment of adult patients ...

17 August 2015 - Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of ...

19 August 2015 - PHARMAC sought feedback on our proposed approach to market share procurement (MSP) for hospital medical devices in ...

The August 2015 issue of the New Zealand Pharmaceutical Schedule is out and now in effect. The schedule includes the following new ...

[:content [\N \I \C \E \space \h \a \s \space \i \s \s \u \e \d \  \d \r \a \f \t \space \g \u \i \d \a \n \c \e \  \r \e \c \o \m \m \e \n \d \i \n \g \space \X \t \a \n \d \i \space \( \e \n \z \a \l \u \t \a \m \i \d \e \) \space \a \s \space \a \n \space \o \p \t \i \o \n \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \  \a \d \u \l \t \space \m \e \n \  \w \i \t \h \  \h \o \r \m \o \n \e \space \r \e \l \a \p \s \e \d \space \m \e \t \a \s \t \a \t \i \c \space \p \r \o \s \t \a \t \e \space \c \a \n \c \e \r \. \space \  \F \o \r \space \m \o \r \e " ..."]]

PHARMAC would like to advise all interested parties that we will not be progressing a proposal to remove the ‘three ...

CADTH has received the notice of a pending submission from Novartis for secukinumab for patients with moderate to severe plaque psoriasis. ...

Patients with thyroid cancer, Crohn’s disease and pneumonia will now be offered new treatments after new medicines were made available in ...

[:content [\T \h \e \space \U \K \space \N \H \S \space \i \s \space \t \o \space \b \e \space \a \d \v \i \s \e \d \space \t \h \a \t \space \i \t \space \s \h \o \u \l \d \n \' \t \space \r \o \u \t \i \n \e \l \y \space \p \r \o \v \i \d \e \space \p \e \r \t \u \z \u \m \a \b \space \( \P \e \r \j \e \t \a \) \space \a \s \space \a \space \t \r \e \a \t \m \e \n \t \space \f \o \r \space \c \e \r \t \a \i \n \space \p \a \t \i \e \n \t \s " ..."]]

The fixed-dose combination aclidinium bromide/formoterol has been approved since November 2014 for long-term treatment of adults with chronic obstructive pulmonary ...